Abstract
Polysaccharide is a kind of biological material, which has good biocompatibility, non-toxicity, and nonimmunogenicity. So, the polysaccharide has been widely applied in drug delivery system. The chemical modifications of chitosan and hyaluronic acid as drug carriers were summarized herein.
Keywords: Chemical modifications, Chitosan, drug carriers, hyaluronic acid.
Current Organic Synthesis
Title:Chemical Modifications of Two Polysaccharides as Drug Carriers
Volume: 12 Issue: 3
Author(s): Gangliang Huang, Hualiang Huang, Qilin Tang and Xinya Mei
Affiliation:
Keywords: Chemical modifications, Chitosan, drug carriers, hyaluronic acid.
Abstract: Polysaccharide is a kind of biological material, which has good biocompatibility, non-toxicity, and nonimmunogenicity. So, the polysaccharide has been widely applied in drug delivery system. The chemical modifications of chitosan and hyaluronic acid as drug carriers were summarized herein.
Export Options
About this article
Cite this article as:
Huang Gangliang, Huang Hualiang, Tang Qilin and Mei Xinya, Chemical Modifications of Two Polysaccharides as Drug Carriers, Current Organic Synthesis 2015; 12(3) . https://dx.doi.org/10.2174/1570179412666150218201607
DOI https://dx.doi.org/10.2174/1570179412666150218201607 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
Related Journals
Related Books

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Artemisinin, Promising Lead Natural Product for Various Drug Developments
Mini-Reviews in Medicinal Chemistry Microglial Activation and its Implications in the Brain Diseases
Current Medicinal Chemistry Can Dietary Antioxidants Reduce the Incidence of Brain Tumors?
Current Drug Metabolism Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 2. Structural Analogues and Derivatives
Current Drug Targets Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma
Current Cancer Therapy Reviews Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Neuropharmacology Intracellular Calcium, Endothelial Cells and Angiogenesis
Recent Patents on Anti-Cancer Drug Discovery Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics
Current Medicinal Chemistry Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response
Current Pharmaceutical Design Editorial [Hot Topic: SOD Enzymes and Their Mimics in Cancer:Pro- vs Anti-Oxidative Mode of Action-Part II (Guest Editor: Ines Batinic-Haberle)]
Anti-Cancer Agents in Medicinal Chemistry Cannabinoids: Between Neuroprotection and Neurotoxicity
Current Drug Targets - CNS & Neurological Disorders Current Status of Leukemia Cytotherapy - Exploitation with Immune Cells
Current Stem Cell Research & Therapy Population Pharmacokinetics of Phenytoin Based on NONMEM in Patients with Intracranial Tumor During the First Week of Post-Craniotomy
Current Drug Metabolism Identification of Functional Peptides from Natural and Synthetic Products on Their Anticancer Activities by Tumor Targeting
Current Medicinal Chemistry Strategies for Increasing the Solubility and Bioavailability of Anticancer Compounds: β-Lapachone and Other Naphthoquinones
Current Pharmaceutical Design Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates
Anti-Cancer Agents in Medicinal Chemistry The Role of Amitriptyline in the Management of Non-small Cell Lung Cancer
Current Cancer Therapy Reviews Pyruvate Kinase M2: Regulatory Circuits and Potential for Therapeutic Intervention
Current Pharmaceutical Design Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets